Clinical trial
Esomeprazole Magnesium With or Without Aspirin in Preventing Esophageal Cancer…
NCT00474903 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00474903 |
|---|---|
| Title | Esomeprazole Magnesium With or Without Aspirin in Preventing Esophageal Cancer in Patients With Barrett Esophagus |
| Official title | Randomized, Double-Blinded Phase II Trial of Esomeprazole Versus Esomeprazole + Two Doses of Aspirin in Barrett's Esophagus Patients |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Barrett Esophagus, Esophageal Cancer |
| Intervention type | Drug, Other |
| Interventions | acetylsalicylic acid, esomeprazole magnesium, placebo |
| Enrollment | 122 |
| Start date | Apr 1, 2007 |
| Primary completion | Mar 1, 2011 |
| Completion | Jun 1, 2011 |
| First posted | May 17, 2007 |
| Last update posted | Jul 2, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: